Keryx announces marketing approval of ferric citrate in Japan Keryx announced that its Japanese partner, Japan Tobacco has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Under the license agreement with JT and Torii, within 30 days, Keryx will receive a non-refundable payment of $10M for the achievement of the marketing approval milestone. Keryx will also receive double-digit tiered royalties on net sales of Riona in Japan, as well as up to an additional $55M upon the achievement of certain annual net sales milestones.
News For KERX From The Last 14 Days
Check below for free stories on KERX the last two weeks.